Effects of a Three-week Inpatient Pulmonary Rehabilitation Program on Walking Speed in Patients With Chronic Obstructive Pulmonary Disease (COPD) or Interstitial Lung Diseases (ILD)
试验速览
- 阶段
- 不适用
- 入组人数
- 43
- 试验地点
- 1
- 主要终点
- change of maximum walking speed
研究概览
简要总结
The aim of this study is to evaluate the effects of a three-week inpatient pulmonary rehabilitation (PR) program on the walking speed in patients with chronic obstructive (COPD) or interstitial lung disease (ILD).
详细描述
At most german traffic light crossings, a walking speed of 1,2m/sec is required to cross the road in time. Patients who are unable to cross the road at this speed, expose themselves to an increased level of stress and possibly the risk of accidents. Thus, they are discouraged from participating in an active social life.
An UK study (Nolan et al., Thorax 2018) showed that only 10.7% of the 926 patients with moderate COPD attained a walking speed of 1.2m/sec. As PR plays a key role in the management of chronic lung diseases in order to improve patients´ exercise capacity, the aim of this study was to evaluate the PR effects on the Walking Speed in patients with COPD or ILD. The investigators hypothesize that PR improves the ability to cross the road in the appropriate time.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 40 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Participation in a pulmonary Rehabilitation program (Schön Klinik BGL)
- •Indication: COPD or ILD
- •COPD; FEV1 <50%
- •ILD: FVC <70%
- •written informed consent
排除标准
- •non compliance
结局指标
主要结局
change of maximum walking speed
时间窗: Day 1 and Day 21
assessed during a walk of 11m
次要结局
- Change in tension symptoms during a field walk test(Day 1 and Day 21)
- Change in walking speed during a field walk test(Day 1 and Day 21)
- Change in Quality of life: Chronic Respiratory Disease Questionnaire (CRQ)(Day 1 and Day 21)
- Change of usual walking Speed(Day 1 and Day 21)
- Change in balance(Day 1 and Day 21)
- Change in maximum leg strength(Day 1 and Day 21)
- Change in illness perception(Day 1 and Day 21)
- Change of exercise capacity(Day 1 and Day 21)
- Change of frailty (FFP)(Day 1 and Day 21)
- Change in anxiety and Depression symptoms(Day 1 and Day 21)
- Change in COPD-related fears on disease-specific disability(Day 1 and Day 21)
研究者
Klaus Kenn
Prof. Dr. Klaus Kenn
Schön Klinik Berchtesgadener Land